Magdalena Król
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Immunology top 10%
- Co-authors
- Bartłomiej TaciakKarol PawłowskiMaciej BiałasekŁukasz KiragaT. MotylI. DolkaKinga MajchrzakJoanna Mucha
- Topics
- Veterinary Oncology Research (19 papers)Cancer Cells and Metastasis (17 papers)Immune cells in cancer (11 papers)
- Cited by
- Cancer ResearchOncologySmall Animals
In The Last Decade
Magdalena Król
77 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 137
- Molecular Biology 790
- Oncology 467
- Pulmonary and Respiratory Medicine 453
- Cancer Research 274
- Immunology 272
Countries citing papers authored by Magdalena Król
This map shows the geographic impact of Magdalena Król's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Król with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Król more than expected).
Fields of papers citing papers by Magdalena Król
This network shows the impact of papers produced by Magdalena Król. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Król. The network helps show where Magdalena Król may publish in the future.
Co-authorship network of co-authors of Magdalena Król
This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Król. A scholar is included among the top collaborators of Magdalena Król based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Król. Magdalena Król is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 25 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 25 | |
| 9 | Interferon lambda 2 promotes mammary tumor metastasis via angiogenesis extension and stimulation of cancer cell migration. | 11 |
| 10 | 16 | |
| 11 | 51 | |
| 12 | 42 | |
| 13 | 13 | |
| 14 | 13 | |
| 15 | 11 | |
| 16 | Chemoresistance in cancer - not only a human problem. | 1 |
| 17 | 11 | |
| 18 | 18 | |
| 19 | DNA microarrays in veterinary oncology. | 1 |
| 20 | DNA microarrays – future in oncology research and therapy | 3 |
About Magdalena Król
Magdalena Król is a scholar working on Oncology, Immunology and Biotechnology, having authored 81 papers that have together received 1.8k indexed citations. Recurring topics across this work include Veterinary Oncology Research (19 papers), Cancer Cells and Metastasis (17 papers) and Immune cells in cancer (11 papers). The work is most often cited by research in Cancer Research (274 citations), Oncology (467 citations) and Small Animals (122 citations). Magdalena Król has collaborated with scholars based in Poland, Italy and Russia. Frequent co-authors include Bartłomiej Taciak, Karol Pawłowski, Maciej Białasek, Łukasz Kiraga, T. Motyl, I. Dolka, Kinga Majchrzak, Joanna Mucha, Tomasz P. Rygiel and R. Sapierzyński. Their work appears in journals such as PLoS ONE, Coordination Chemistry Reviews and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.